MedPath

ZEVALIN 1,6 mg/ml, EQUIPO REACTIVO PARA LA PREPARACION DE UN RADIOFARMACO PARA PERFUSION

ZEVALIN 1,6 mg/ml, EQUIPO REACTIVO PARA LA PREPARACION DE UN RADIOFARMACO PARA PERFUSION

Commercialized
Register Number

03264001

Prescription Type

Uso Hospitalario

Authorization Date

Feb 17, 2004

Dosage Form

EQUIPO DE REACTIVOS PARA PREPARACIÓN RADIOFARMACÉUTICA

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number03264001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

IBRITUMOMAB TIUXETANActive
Quantity: 1,6 mg
Name: IBRITUMOMAB TIUXETAN

ATC CLASSIFICATION (3)

V10X
V10XX
V10XX02

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.